Regarding Alzheimer’s disease, a cross-sectional study reported substantially higher levels of circulating MIG (CXCL9) in patients with Alzheimer’s disease compared to non-cognitively impaired and mildly-cognitively impaired participants (Lee et al., 2008). This evidence concerns the gene CXCL9 and Alzheimer disease.